Full dose, half dose, or discontinuation of etanercept biosimilar in early axial spondyloarthritis patients: a real-world study in China.
Li, Kun-Peng
Full dose, half dose, or discontinuation of etanercept biosimilar in early axial spondyloarthritis patients: a real-world study in China. [electronic resource] - Archives of medical science : AMS May 2019 - 700-705 p. digital
Publication Type: Journal Article
1734-1922
10.5114/aoms.2018.76141 doi
Full dose, half dose, or discontinuation of etanercept biosimilar in early axial spondyloarthritis patients: a real-world study in China. [electronic resource] - Archives of medical science : AMS May 2019 - 700-705 p. digital
Publication Type: Journal Article
1734-1922
10.5114/aoms.2018.76141 doi